Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative Neoplasms
NCT ID: NCT03688490
Last Updated: 2019-07-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
70 participants
OBSERVATIONAL
2013-07-17
2013-11-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Prospective work based on the distribution of a dedicated questionnaire.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Frequency and Characteristics of Pruritus in Patients With Monoclonal Gammopathy
NCT03832140
Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study
NCT06614998
The Role of the Coagulation Pathways in Recurrent Angioedema
NCT02892682
Splenectomy as a Treatment for Patient With Relapsed Haemophagocytic Lymphohistiocytosis of Unknown Etiology
NCT02862054
Interferon-pegyle α2a Efficiency and Tolerance in Myelofibrosis
NCT02910258
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Distribution of the questionnaire to each patients with myeloproliferative neoplasms (treated or not) suffering from aquagenic pruritus.
Analyse of each characteristic of the aquagenic pruritus by a statistician and publication at the end.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* suffering from aquagenic pruritus
Exclusion Criteria
* No written informed consent
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
IANOTTO Jean-Christophe, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Hématologie Clinique-Institut de Cancéro-Hématologie
References
Explore related publications, articles, or registry entries linked to this study.
Le Gall-Ianotto C, Brenaut E, Gouillou M, Lacut K, Nowak E, Tempescul A, Berthou C, Ugo V, Carre JL, Misery L, Ianotto JC. Clinical characteristics of aquagenic pruritus in patients with myeloproliferative neoplasms. Br J Dermatol. 2017 Jan;176(1):255-258. doi: 10.1111/bjd.14809. Epub 2016 Dec 22. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PASYMPLE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.